Reports to FDA of fatal anaphylaxis associated with intravenous iron products
Lynda McCulley(Center for Drug Evaluation and Research), Peter Waldron(Center for Drug Evaluation and Research), Sarah Harris(Center for Drug Evaluation and Research), Kate Gelperin(United States Food and Drug Administration), Cunlin Wang, Steven T. Bird(Brigham and Women's Hospital)
Cited by 24
Related Papers
Risk of venous thromboembolism in women with polycystic ovary syndrome: a population-based matched cohort analysis
|Canadian Medical Association Journal|2012|120
Isotretinoin and Risk for Inflammatory Bowel Disease
|JAMA Dermatology|2013|93
Risk of acute kidney injury associated with the use of fluoroquinolones
|Canadian Medical Association Journal|2013|89